160 related articles for article (PubMed ID: 32458631)
1. Cytotoxic and Antimetastatic Activity of Hesperetin and Doxorubicin Combination Toward Her2 Expressing Breast Cancer Cells.
Nurhayati IP; Khumaira A; Ilmawati GPN; Meiyanto E; Hermawan A
Asian Pac J Cancer Prev; 2020 May; 21(5):1259-1267. PubMed ID: 32458631
[TBL] [Abstract][Full Text] [Related]
2. In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells.
Amalina ND; Salsabila IA; Zulfin UM; Jenie RI; Meiyanto E
J Egypt Natl Canc Inst; 2023 Mar; 35(1):6. PubMed ID: 36967442
[TBL] [Abstract][Full Text] [Related]
3. The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells.
Jenie RI; Handayani S; Susidarti RA; Udin LZ; Meiyanto E
Adv Pharm Bull; 2018 Aug; 8(3):507-516. PubMed ID: 30276148
[No Abstract] [Full Text] [Related]
4. Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor.
Shi J; Li J; Li J; Li R; Wu X; Gao F; Zou L; Mak WWS; Fu C; Zhang J; Leung GP
Phytomedicine; 2021 Jan; 81():153408. PubMed ID: 33234363
[TBL] [Abstract][Full Text] [Related]
5. Combination of Potassium Pentagamavunon-0 and Doxorubicin Induces Apoptosis and Cell Cycle Arrest and Inhibits Metastasis in Breast Cancer Cells.
Putri H; Jenie RI; Handayani S; Kastian RF; Meiyanto E
Asian Pac J Cancer Prev; 2016; 17(5):2683-8. PubMed ID: 27268651
[TBL] [Abstract][Full Text] [Related]
6. CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti- Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells.
Novitasari D; Jenie RI; Utomo RY; Kato JY; Meiyanto E
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1827-1836. PubMed ID: 34181339
[TBL] [Abstract][Full Text] [Related]
7. Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells.
Choupani J; Alivand MR; M Derakhshan S; Zaeifizadeh M; S Khaniani M
J Cell Physiol; 2019 Jun; 234(6):9093-9104. PubMed ID: 30317622
[TBL] [Abstract][Full Text] [Related]
8. Lapatinib inhibits doxorubicin induced migration of HER2-positive breast cancer cells.
Chintalaramulu N; Vadivelu R; Nguyen NT; Cock IE
Inflammopharmacology; 2020 Oct; 28(5):1375-1386. PubMed ID: 32378049
[TBL] [Abstract][Full Text] [Related]
9. Revealing the Reversal Effect of Galangal (Alpinia galanga L.) Extract Against Oxidative Stress in Metastatic Breast Cancer Cells and Normal Fibroblast Cells Intended as a Co- Chemotherapeutic and Anti-Ageing Agent.
Ahlina FN; Nugraheni N; Salsabila IA; Haryanti S; Da'i M; Meiyanto E
Asian Pac J Cancer Prev; 2020 Jan; 21(1):107-117. PubMed ID: 31983172
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Cytotoxic and Antimigratory Effect of Brazilein and Doxorubicin on HER2-Overexpressing Cells.
Handayani S; Susidarti RA; Utomo RY; Meiyanto E; Jenie RII
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2623-2632. PubMed ID: 36037115
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.
Tun JO; Salvador-Reyes LA; Velarde MC; Saito N; Suwanborirux K; Concepcion GP
Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31527453
[TBL] [Abstract][Full Text] [Related]
12. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
13. Hsp90 Inhibitor; NVP-AUY922 in Combination with Doxorubicin Induces Apoptosis and Downregulates VEGF in MCF-7 Breast Cancer Cell Line.
Mohammadian M; Feizollahzadeh S; Mahmoudi R; Toofani Milani A; Rezapour-Firouzi S; Karimi Douna B
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1773-1778. PubMed ID: 32592377
[TBL] [Abstract][Full Text] [Related]
14. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
15. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antimetastatic and anticancer activities of morin in HER2‑overexpressing breast cancer SK‑BR‑3 cells.
Lee KS; Lee MG; Nam KS
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982761
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic effect of hesperetin on doxorubicin-induced testicular toxicity: Potential roles of the mechanistic target of rapamycin kinase (mTOR) and dynamin-related protein 1 (DRP1).
Tektemur A; Tektemur NK; Güzel EE
Toxicol Appl Pharmacol; 2022 Jan; 435():115833. PubMed ID: 34933056
[TBL] [Abstract][Full Text] [Related]
19. Combined doxorubicin and arctigenin treatment induce cell cycle arrest-associated cell death by promoting doxorubicin uptake in doxorubicin-resistant breast cancer cells.
Lee MG; Lee KS; Nam KS
IUBMB Life; 2023 Sep; 75(9):765-777. PubMed ID: 37492896
[TBL] [Abstract][Full Text] [Related]
20. Various concentrations of hesperetin induce different types of programmed cell death in human breast cancerous and normal cell lines in a ROS-dependent manner.
Samandari-Bahraseman MR; Khorsand B; Zareei S; Amanlou M; Rostamabadi H
Chem Biol Interact; 2023 Sep; 382():110642. PubMed ID: 37487865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]